The pharmacology of Malo maxima jellyfish venom extract in isolated cardiovascular tissues: A probable cause of the Irukandji syndrome in Western Australia
about
Cardiovascular effect is independent of hemolytic toxicity of tentacle-only extract from the jellyfish Cyanea capillataJellyfish stings and their management: a reviewPharmacological studies of tentacle extract from the jellyfish Cyanea capillata in isolated rat aortaβ adrenergic receptor/cAMP/PKA signaling contributes to the intracellular Ca2+ release by tentacle extract from the jellyfish Cyanea capillata.
P2860
The pharmacology of Malo maxima jellyfish venom extract in isolated cardiovascular tissues: A probable cause of the Irukandji syndrome in Western Australia
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The pharmacology of Malo maxim ...... syndrome in Western Australia
@ast
The pharmacology of Malo maxim ...... syndrome in Western Australia
@en
The pharmacology of Malo maxim ...... syndrome in Western Australia
@nl
type
label
The pharmacology of Malo maxim ...... syndrome in Western Australia
@ast
The pharmacology of Malo maxim ...... syndrome in Western Australia
@en
The pharmacology of Malo maxim ...... syndrome in Western Australia
@nl
prefLabel
The pharmacology of Malo maxim ...... syndrome in Western Australia
@ast
The pharmacology of Malo maxim ...... syndrome in Western Australia
@en
The pharmacology of Malo maxim ...... syndrome in Western Australia
@nl
P50
P921
P1433
P1476
The pharmacology of Malo maxim ...... syndrome in Western Australia
@en
P2093
P304
P356
10.1016/J.TOXLET.2011.01.003
P407
P577
2011-01-13T00:00:00Z